Yesim Parman-Gulsen
Istanbul, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Eculizumab as a Rescue Therapy in Prolonged Myasthenic Crisis in the Intensive Care Unit: A Case Series.
Journal: Neurocritical care
Published: December 10, 2024
An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis.
Journal: Acta neurologica Scandinavica
Published: February 25, 2021
Late-onset generalized myasthenia gravis: clinical features, treatment, and outcome.
Journal: Acta neurologica Belgica
Published: May 27, 2019
The effect of interleukin (IL)-21 and CD4+ CD25++ T cells on cytokine production of CD4+ responder T cells in patients with myasthenia gravis.
Journal: Clinical and experimental immunology
Published: June 22, 2017
Prompt Response to Prednisone Predicts Benign Course in MuSK-MG.
Journal: European neurology
Published: March 23, 2017
Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 15, 2016
Regulatory function of CD4+CD25++ T cells in patients with myasthenia gravis is associated with phenotypic changes and STAT5 signaling: 1,25-Dihydroxyvitamin D3 modulates the suppressor activity.
Journal: Journal of neuroimmunology
Published: January 15, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026